Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001602474-26-000004
Filing Date
2026-07-30
Accepted
2026-07-30 16:04:33
Documents
1
Period of Report
2026-05-14

Document Format Files

Seq Description Document Type Size
1 form4-07302026_080728.html 4  
1 form4-07302026_080728.xml 4 7467
  Complete submission text file 0001602474-26-000004.txt   9233
Mailing Address 2 HEADQUARTERS PLAZA EAST BUILDING, 11TH FLOOR MORRISTOWN NJ 07960
Business Address 2 HEADQUARTERS PLAZA EAST BUILDING, 11TH FLOOR MORRISTOWN NJ 07960 551-321-2234
Whitehawk Therapeutics, Inc. (Issuer) CIK: 0001422142 (see all company filings)

EIN.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 88 KEARNY STREET, SUITE 1800 SAN FRANCISCO CA 94108
Business Address
Dalal Anupam (Reporting) CIK: 0001602474 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38560 | Film No.: 261223235